Menu Back toSS02: Preparations for Unexpected Infections from the COVID- 19 Pandemic:Rapid Development and Supply of Vaccines and Drugs for Patients

18th DIA Japan Annual Meeting 2021

All prices are exclusive of 10% Japanese consumption tax

SS02: Preparations for Unexpected Infections from the COVID- 19 Pandemic:Rapid Development and Supply of Vaccines and Drugs for Patients

Session Chair(s)

Akiko  Ikeda, RPh

Akiko Ikeda, RPh

  • Associate Director, Regulatory Development Dept.
  • Janssen Pharmaceutical K.K., Japan
Mari  Ariyasu

Mari Ariyasu

  • Head of Project Management 4, Senior Director
  • Shionogi & Co., Ltd., Japan

Speaker(s)

Kazuhiro  Tateda, MD, PhD

Kazuhiro Tateda, MD, PhD

  • Professor, Department of Microbiology and Infectious Diseases
  • Toho University, Japan
Noriko  Morikubo

Noriko Morikubo

  • Regulatory Strategy Group2, Japan Regulatory Portfolio Lead
  • Pfizer R&D Japan G.K., Japan
Satoshi  Aida

Satoshi Aida

  • Chief Planner, Strategic Planning Department
  • Teijin Pharma Limited, Japan

Contact us